1.00
Shattuck Labs Inc Borsa (STTK) Ultime notizie
Shattuck Labs Inc. stock retracement – recovery analysisDip Buying & Stepwise Trade Execution Plans - Newser
What earnings revisions data tells us about Shattuck Labs Inc.Market Risk Summary & Daily Chart Pattern Signals - Newser
Tools to assess Shattuck Labs Inc.’s risk profileQuarterly Earnings Summary & Real-Time Volume Analysis - Newser
How to recover losses in Shattuck Labs Inc. stockWeekly Gains Report & Risk Adjusted Buy/Sell Alerts - Newser
Galapagos Nv shares rise 1.16% premarket after Shattuck Labs, Inc. announced board changes. - AInvest
Analyzing recovery setups for Shattuck Labs Inc. investors2025 Price Momentum & Weekly Hot Stock Watchlists - Newser
Shattuck Labs Inc. stock prediction for this weekJuly 2025 Trade Ideas & Risk Adjusted Buy/Sell Alerts - Newser
Shattuck Labs Inc. stock chart pattern explained2025 Macro Impact & Weekly Chart Analysis and Guides - Newser
Will a bounce in Shattuck Labs Inc. offer an exit2025 Institutional Moves & Short-Term Trading Alerts - Newser
How hedge fund analytics apply to Shattuck Labs Inc. stockGlobal Markets & Free Reliable Trade Execution Plans - Newser
Is Shattuck Labs Inc. stock bottoming outRecession Risk & Low Risk High Reward Ideas - Newser
Is Shattuck Labs Inc. building a consolidation baseJuly 2025 Outlook & High Accuracy Trade Alerts - Newser
Visual trend scoring systems applied to Shattuck Labs Inc.Quarterly Portfolio Summary & Growth-Oriented Investment Plans - Newser
What earnings revisions data tells us about Shattuck Labs IncQuarterly Trade Report & Precise Buy Zone Tips - Newser
Shattuck Labs Closes Up to $100 Million Private Placement - citybiz
Shattuck Labs Closes $103M Private Placement Deal - MSN
Galapagos Nv shares rise 1.07% intraday after Shattuck Labs, Inc. announced board changes. - AInvest
Quantitative breakdown of Shattuck Labs Inc. recent moveShare Buyback & Real-Time Buy Signal Notifications - Newser
Leading vs lagging indicators on Shattuck Labs Inc. performanceJuly 2025 Volume & AI Driven Stock Reports - Newser
Analyzing Shattuck Labs Inc. with multi timeframe chartsJuly 2025 Pullbacks & Long-Term Growth Plans - Newser
Shattuck Labs shares fall 2.42% intraday after announcing board and committee changes and private placement funding. - AInvest
Zentalis Pharmaceuticals shares rise 2.20% premarket after Shattuck Labs corporate presentation. - AInvest
Shattuck Labs closes $103 million private placement led by OrbiMed - Investing.com
Shattuck Labs Secures $103 Million in Private Placement to Advance SL-325 for Autoimmune Diseases and Appoints New Board Members - Quiver Quantitative
Shattuck Labs announces closing of up to $103M placement - AInvest
$103M Funding to Advance Novel IBD Drug: Shattuck Labs Strengthens Board with J&J Immunology Expert - Stock Titan
Published on: 2025-08-25 23:26:45 - Newser
Published on: 2025-08-25 05:38:50 - Newser
Shattuck Labs Inc.’s Price Action Aligns with Quant SignalsMarket Performance Summary & Real-Time Volume Spike Alerts - beatles.ru
Can you recover from losses in Shattuck Labs Inc.Market Sentiment Summary & AI Based Trade Execution Alerts - Newser
Candlestick signals on Shattuck Labs Inc. stock todayChart Signals & Reliable Price Action Trade Plans - Newser
H.C. Wainwright maintains Neutral rating on Shattuck Labs stock as FDA clears IND - Investing.com Canada
IND open for Shattuck’s SL-325 for inflammatory bowel disease - BioWorld MedTech
Intraday Charts Show Spike in Shattuck Labs Inc. Activity2025 Momentum Check & Free Weekly Chart Analysis and Trade Guides - beatles.ru
Shattuck Labs Reports Q2 2025 Financial Results - TipRanks
Is Shattuck Labs Inc. Starting a New UptrendWeekly Stock Analysis & Safe Capital Growth Stock Tips - classian.co.kr
Will Shattuck Labs Inc. stock hit new highs in YEARWeekly Trend Summary & Precise Swing Trade Alerts - theviewers.co.kr
Shattuck Labs shares fall 8.71% intraday despite positive IND approval for SL-325. - AInvest
Shattuck Labs and the Emerging DR3 Target Opportunity in IBD Therapy: A Strategic and Financial Catalyst Analysis - AInvest
Shattuck Labs Says Investigational New Drug Application for SL-325 in Effect - MarketScreener
Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease - The Manila Times
Shattuck Labs Announces Advancement of Phase 1 Clinical Trial for SL-325, a Potential First-in-Class DR3 Antagonist Antibody for Inflammatory Bowel Disease - Quiver Quantitative
First-Ever DR3 Blocking Antibody: Shattuck Labs' IBD Drug SL-325 Cleared for Human Trials with $103M Runway - Stock Titan
Bullish Divergence Spotted in Shattuck Labs Inc. Momentum2025 Volume Leaders & Daily Profit Focused Stock Screening - beatles.ru
Sector ETF Data Correlates with Strength in Shattuck Labs Inc.July 2025 Momentum & Verified Momentum Stock Ideas - 더경남뉴스
Candlestick Signal Suggests Reversal in Shattuck Labs Inc.July 2025 WrapUp & Step-by-Step Swing Trade Plans - 더경남뉴스
Will Shattuck Labs Inc. announce a stock splitJuly 2025 Chart Watch & Weekly Hot Stock Watchlists - 더경남뉴스
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):